[ Price : $8.95]
Federal Register Notice: FDA seeks comments on information collection requirements related to blood establishment registration and...[ Price : $8.95]
FDA sets a 9/29 user fee review action target date for a Salix Pharmaceuticals resubmitted supplemental NDA for Relistor (methylna...[ Price : $8.95]
Celltrion files a 351(k) application seeking approval for Remsima, a biosimilar version of Janssen Biotechs Remicade (infliximab)....[ Price : $8.95]
FDAs Center for Veterinary Medicine reports gains in lowering the incidence of foodborne antibiotic resistance, along with some wo...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on a guidance on enforcing adverse event reporting requirements during an influenza pa...[ Price : $8.95]
Law firm Ropes & Gray says there are concerns that FDAs final guidance entitled the 510(k) Program: Evaluating Substantial Equival...[ Price : $8.95]
FDA slips in the annual agency rankings of Best Places to Work in the Federal Government.[ Price : $8.95]
CDERs Office of Prescription Drug Promotion sends an untitled letter to Covis Pharmaceuticals over a physician letter promoting La...